These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4591912)

  • 21. The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine.
    Lucas AO; Hendrickse RG; Okubadejo OA; Richards WH; Neal RA; Kofie BA
    Trans R Soc Trop Med Hyg; 1969; 63(2):216-29. PubMed ID: 4893737
    [No Abstract]   [Full Text] [Related]  

  • 22. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae.
    Menendez C; Todd J; Alonso PL; Lulat S; Francis N; Greenwood BM
    J Trop Med Hyg; 1994 Aug; 97(4):244-8. PubMed ID: 8064949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug prevention of malaria.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6268):988-9. PubMed ID: 6781690
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on anti-folate antimalarials in east Africa.
    Ortelli F; Maxwell CA; Curtis J; Watkins WM
    Parassitologia; 1999 Sep; 41(1-3):313-4. PubMed ID: 10697874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria prophylaxis for travellers.
    Cook IF
    Med J Aust; 1985 Apr; 142(7):427. PubMed ID: 3884983
    [No Abstract]   [Full Text] [Related]  

  • 26. Malaria prophylaxis.
    Fox JS
    Med J Aust; 1981 Aug; 2(4):202-3. PubMed ID: 7029226
    [No Abstract]   [Full Text] [Related]  

  • 27. Malaria: uncomplicated, caused by Plasmodium falciparum.
    Taylor-Robinson D; Jones K; Garner P
    Clin Evid; 2005 Jun; (13):988-1009. PubMed ID: 16135285
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimalarial effects of sulphormethoxine, diaphenylsulphone and separate combinations of these with pyrimethamine: a review of preliminary investigations carried out in Tanzania.
    Laing AB
    J Trop Med Hyg; 1968 Feb; 71(2):27-35. PubMed ID: 4867507
    [No Abstract]   [Full Text] [Related]  

  • 29. Malaria chemoprophylaxis for multiple drug resistant Plasmodium falciparum in Africa: an increasing problem.
    van der Kaay HJ; Overbosch D; Stuiver PC; Wismans PJ
    Trop Geogr Med; 1984 Dec; 36(4):317-22. PubMed ID: 6396911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
    Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ
    Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis.
    Otoo LN; Riley EM; Menon A; Byass P; Greenwood BM
    Trans R Soc Trop Med Hyg; 1989; 83(6):778-82. PubMed ID: 2515634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malaria prophylaxis for visitors to Papua New Guinea.
    Black RH
    Med J Aust; 1978 Oct; 2(8):384. PubMed ID: 366358
    [No Abstract]   [Full Text] [Related]  

  • 33. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis.
    Greenwood BM; David PH; Otoo-Forbes LN; Allen SJ; Alonso PL; Armstrong Schellenberg JR; Byass P; Hurwitz M; Menon A; Snow RW
    Trans R Soc Trop Med Hyg; 1995; 89(6):629-33. PubMed ID: 8594677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artemether-pyrimethamine in the treatment of pyrimethamine-resistant falciparum malaria.
    Na-Bangchang K; Tipwangso P; Thanavibul A; Tan-ariya P; Suprakob K; Kanda T; Karbwang J
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):19-23. PubMed ID: 9031394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Resistance of Plasmodium falciparum in the Brazilian Amazonas to the combination of sulfadoxine and pyrimethamine].
    Alecrim M das G; Alecrim WD; de Albuquerque BC; Dourado HV; Wanssa Mdo C
    Rev Inst Med Trop Sao Paulo; 1982; 24(6 Suppl):44-7. PubMed ID: 6764287
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of dapsone-pyrimethamine on immunoglobulin concentrations in malaria chemoprophylaxis.
    Ti TY; Jacob E; Wee YJ
    Trans R Soc Trop Med Hyg; 1987; 81(2):245-6. PubMed ID: 3303481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous estimation of serum concentrations of dapsone, monoacetyldapsone, and pyrimethamine in Chinese men on maloprim for malaria prophylaxis using reversed-phase high performance liquid chromatography.
    Lee HS; Ti TY; Lee PS; Yap CL
    Ther Drug Monit; 1985; 7(4):415-20. PubMed ID: 3909534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vivo resistance of Plasmodium falciparum to the combination of sulfadoxine and pyrimethamine, at RIII level, in Amazonas, Brazil].
    Alecrim WD; Dourado H; Alecrim M das G; Passos LF; Wanssa E; Albuquerque B
    Rev Inst Med Trop Sao Paulo; 1982; 24(6 Suppl):52-3. PubMed ID: 6764290
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of malaria.
    Thomson NP
    N Z Med J; 1980 Mar; 91(655):194. PubMed ID: 6929994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.